E-LIB Suche - Ergebnisse für: Cegla, J.

1

Lomitapide hepatic safety: A long-term retrospective analys..:

Cegla, J. ; Larrey, D. ; D'Erasmo, L...
Atherosclerosis Plus. 54 (2023) - p. S2-S3 , 2023

Link: https://doi.org/10.1016/..

2

Lomitapide in the long-term real-world management of HoFH –..:

Cegla, J. ; d'Erasmo, L. ; Steward, K....
Atherosclerosis Plus. 49 (2022) - p. S2-S3 , 2022

Link: https://doi.org/10.1016/..

3

Cardiovascular disease morbidity is associated with social ..:

Iyen, B. ; Qureshi, N. ; Roderick, P....
Atherosclerosis Plus. 49 (2022) - p. S4-S5 , 2022

Link: https://doi.org/10.1016/..

4

The effect of adjusting LDL-cholesterol for Lipoprotein(a)-..:

Thayabaran, D. ; Tsui, A.P.T. ; Ebmeier, S.J....
Atherosclerosis Plus. 49 (2022) - p. S3 , 2022

Link: https://doi.org/10.1016/..

5

Lipoprotein (a) – Current status in the UK:

Ansari, S. ; Neely, D. ; Payne, J..
Atherosclerosis Plus. 49 (2022) - p. S2 , 2022

Link: https://doi.org/10.1016/..

6

Lipoprotein apheresis reduces SARS-CoV-2 S protein antibody..:

Valaiyapathi, R. ; Barton, L. ; Carvalho, L....
Atherosclerosis Plus. 49 (2022) - p. S3-S4 , 2022

Link: https://doi.org/10.1016/..

7

Inpatient management of severe hypertriglyceridaemia at a t..:

Yang, W. ; Misra, S. ; Cegla, J..
Atherosclerosis Plus. 43 (2021) - p. S9 , 2021

Link: https://doi.org/10.1016/..

8

Absence of coronary artery calcium does not exclude coronar..:

Israni, A. ; Hart, T. ; Cegla, J..
Atherosclerosis Plus. 43 (2021) - p. S7 , 2021

Link: https://doi.org/10.1016/..

9

Lipoprotein(a) as a biomarker for subclinical coronary and ..:

Low, B. ; Trivedi, N. ; Loh, W.J...
Atherosclerosis. 331 (2021) - p. e113-e114 , 2021

Link: https://doi.org/10.1016/..

10

APOE gene testing in FH referrals – the story so far:

Duff-Farrier, C. ; Pennock, M. ; Watson, E....
Atherosclerosis Plus. 43 (2021) - p. S2 , 2021

Link: https://doi.org/10.1016/..

11

Reduction in cardiovascular disease morbidity of men and wo..:

Iyen, B. ; Qureshi, N. ; Roderick, P....
Atherosclerosis Plus. 43 (2021) - p. S5 , 2021

Link: https://doi.org/10.1016/..

12

Statin treatment reduces plasma FGF19 in healthy volunteers..:

Haqiqi, A. ; Cegla, J. ; Jones, B.
Atherosclerosis. 315 (2020) - p. e153-e154 , 2020

Link: https://doi.org/10.1016/..

13

Coronary Calcium Score In Patients With Clinical Criteria F..:

David, A. ; Hart, T. ; Cegla, J....
Atherosclerosis Supplements. 38 (2019) - p. e2 , 2019

Link: https://doi.org/10.1016/..

14

Evolocumab therapy and a possible association with skin rea..:

Ragavan, A. ; David, A. ; Scott, J...
Atherosclerosis Supplements. 38 (2019) - p. e7 , 2019

Link: https://doi.org/10.1016/..

15

Three years experience of lomitapide therapy in the uk:

Cegla, J. ; Walji, S. ; Neuwirth, C....
Atherosclerosis Supplements. 38 (2019) - p. e6-e7 , 2019

Link: https://doi.org/10.1016/..